Wells Fargo downgraded Bausch + Lomb (BLCO) to Equal Weight from Overweight with a price target of $15, down from $24.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BLCO:
- Bausch + Lomb price reaction to recall ‘likely overdone,’ says RBC Capital
- BofA sees Bausch + Lomb IOL recall news as positive for RxSight
- Bausch + Lomb Initiates Voluntary Recall of enVista Intraocular Lenses
- Bausch + Lomb announces recall of intraocular lenses on enVista platform
- Bausch + Lomb to Announce Q1 2025 Financial Results